Indaptus Therapeutics Inc is trading 5.1% down at $3.53 in pre-market, extending a pullback that started after a sharp multi-day rally last week.
- The stock is experiencing continued profit-taking following significant gains of 20.99% and 45.71% recorded on June 10–11, 2026.
- Selling pressure intensified during after-hours trading on June 16, following the recent price surge.
- There are currently no fresh company-specific announcements or major new catalysts driving the downward movement this morning.